Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Merus NV (MRUS)
NASDAQ:MRUS
Merus (MRUS) Stock Price & Analysis
160 Followers
MRUS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$12.03 - $30.81
Previous Close$17.4
Volume333.65K
Average Volume (3M)251.33K
Market Cap
$804.30M
Enterprise Value$805.92M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-6.1
Beta0.96
Next Earnings
May 08, 2023EPS Estimate
-$1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.87
Shares Outstanding46,317,281
10 Day Avg. Volume269,393
30 Day Avg. Volume251,334
Standard Deviation0.18
R-Squared0.05
Alpha0.00982
Financial Highlights & Ratios
Price to Book (P/B)3.69
Price to Sales (P/S)19.56
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-5.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue26.06
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-7.65
Forecast
1Y Price Target
$37.50Price Target Upside115.95% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Merus News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MRUS FAQ
What was Merus NV’s price range in the past 12 months?
Merus NV lowest stock price was $12.03 and its highest was $30.81 in the past 12 months.
What is Merus NV’s market cap?
Currently, no data Available
When is Merus NV’s upcoming earnings report date?
Merus NV’s upcoming earnings report date is May 08, 2023 which is in 38 days.
How were Merus NV’s earnings last quarter?
Merus NV released its earnings results on Feb 28, 2023. The company reported -$1.83 earnings per share for the quarter, missing the consensus estimate of -$0.948 by -$0.882.
Is Merus NV overvalued?
According to Wall Street analysts Merus NV’s price is currently Undervalued.
Does Merus NV pay dividends?
Merus NV does not currently pay dividends.
What is Merus NV’s EPS estimate?
Merus NV’s EPS estimate is -$1.
How many shares outstanding does Merus NV have?
Merus NV has 46,317,280 shares outstanding.
What happened to Merus NV’s price movement after its last earnings report?
Merus NV reported an EPS of -$1.83 in its last earnings report, missing expectations of -$0.948. Following the earnings report the stock price went up 2.045%.
Which hedge fund is a major shareholder of Merus NV?
Among the largest hedge funds holding Merus NV’s share is Deerfield Management Company, LP. It holds Merus NV’s shares valued at 37M.
---
Merus Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$37.50 (115.95% Upside)
$37.50 (115.95% Upside)
Blogger Sentiment
Bullish
MRUS Sentiment 80%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 1.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 4.3%
Last 30 Days ▼ 4.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.02%
12-Months-Change
Fundamentals
Return on Equity
-46.58%
Trailing 12-Months
Asset Growth
-16.99%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Merus NV
Merus NV is a clinical-stage immune-oncology company, which engages in the discovery and development of bi-specific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg on June 16, 2003 and is headquartered in Utrecht, Netherlands.
---
Top 5 ETFs holding MRUS
BMO MSCI Innovation Index ETF
$7.46K
Up to five ETFs with an Outperform Smart Score that hold MRUS. The ETFs are listed according to market value of MRUS within the ETF
---
---